Pancreatic Neuroendocrine Neoplasms and Gastrointestinal Stromal Tumors: A Single-Institution Experience of a Rare Association and Review of the Literature.
Aged
Biomarkers, Tumor
/ metabolism
Diagnostic Imaging
/ methods
Female
Follow-Up Studies
Gastrointestinal Neoplasms
/ diagnostic imaging
Gastrointestinal Stromal Tumors
/ diagnostic imaging
Humans
Male
Middle Aged
Neoplasms, Multiple Primary
/ diagnostic imaging
Neuroendocrine Tumors
/ diagnostic imaging
Outcome Assessment, Health Care
Pancreatic Neoplasms
/ diagnostic imaging
Journal
Pancreas
ISSN: 1536-4828
Titre abrégé: Pancreas
Pays: United States
ID NLM: 8608542
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
14
7
2020
medline:
3
8
2021
entrez:
14
7
2020
Statut:
ppublish
Résumé
Pancreatic neuroendocrine neoplasms (pNENs) and gastrointestinal stromal tumors (GISTs) represent rare neoplasms. Nonsyndromic cases of pNENs associated with a synchronous GIST were evaluated, and a review of the literature was performed. We evaluated clinicopathologic features, postoperative outcome, and follow-up of patients operated on for nonsyndromic synchronous pNENs and GISTs in our unit (2003-2017). Five (3.2%) of 156 patients with a pNEN had an associated GIST (3 male/2 female; average age, 67 years). They were diagnosed with a pNEN preoperatively and underwent pancreatic surgery. In 4 patients, GISTs were detected intraoperatively. Histology showed 3 G1 and 2 G2 pNENs. All GISTs were low risk (median size, 0.9 cm). Two patients were alive without disease 108 and 132 months after surgery. In the literature, 7 cases were described. They had low-risk GISTs, with a gastric location in 6 cases (median size, 2.85 cm). Sporadic pNENs coexisting with a GIST have been demonstrated in 12 cases. This association is considered fortuitous, and its true incidence may be underestimated. Surgery should be performed on the GIST during the pancreatic surgery. The prognosis strictly depends on the pancreatic NENs.
Identifiants
pubmed: 32658075
doi: 10.1097/MPA.0000000000001599
pii: 00006676-202008000-00008
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
918-923Références
Massironi S, Sciola V, Peracchi M, et al. Neuroendocrine tumors of the gastro-entero-pancreatic system. World J Gastroenterol. 2008;14:5377–5384.
Anderson CW, Bennett JJ. Clinical presentation and diagnosis of pancreatic neuroendocrine Tumors. Surg Oncol Clin N Am. 2016;25:363–374.
Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469–1492.
Tavares AB, Viveiros FA, Cidade CN, et al. Gastric GIST with synchronous neuroendocrine tumour of the pancreas in a patient without neurofibromatosis type 1. BMJ Case Rep. 2012;2012:bcr0220125895.
Alabraba E, Bramhall S, O'Sullivan B, et al. Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1. World J Surg Oncol. 2009;7:18.
Biasco G, Velo D, Angriman I, et al. Gastrointestinal stromal tumors: report of an audit and review of the literature. Eur J Cancer Prev. 2009;18:106–116.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130:1466–1478.
Ueda K, Hijioka M, Lee L, et al. A synchronous pancreatic neuroendocrine tumor and duodenal gastrointestinal stromal tumor. Intern Med. 2014;53:2483–2488.
Klimstra DS. Neuroendocrine neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon, France: IARC Press; 2010:322–326.
Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401.
American Joint Committee on Cancer. Chapter 43: Gastrointestinal stromal tumor. In: Amin MB, Edge S, Greene F, et al, eds. AJCC Cancer Staging Manual. 8th ed. New York, NY: Springer; 2017:226–232.
Kövér E, Faluhelyi Z, Bogner B, et al. [Dual Tumours in the GI Tract: Synchronous and Metachronous Stromal (GIST) and epithelial/neuroendocrine Neoplasms]. [Article in Hungarian]. Magy Onkol. 2004;48:315–321.
Haugvik SP, Røsok BI, Edwin B, et al. Concomitant nonfunctional pancreatic neuroendocrine tumor and gastric GIST in a patient without neurofibromatosis type 1. J Gastrointest Cancer. 2012;43 suppl 1:S171–S174.
Ramos LR, Marques PP, Nogueira J, et al. Gastric gastrointestinal stromal tumor and neuroendocrine pancreatic tumor: always neurofibromatosis? Endosc Ultrasound. 2014;3:254–255.
Arabadzhieva E, Yonkov A, Bonev S, et al. A rare case with synchronous gastric gastrointestinal stromal tumor, pancreatic neuroendocrine tumor, and uterine leiomyoma. World J Surg Oncol. 2016;14:287.
Halfdanarson TR, Rubin J, Farnell MB, et al. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15:409–427.
Ito T, Igarashi H, Jensen RT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract Res Clin Gastroenterol. 2012;26:737–753.
Agaimy A, Wünsch PH, Dirnhofer S, et al. Microscopic gastrointestinal stromal tumors in esophageal and intestinal surgical resection specimens: a clinicopathologic, immunohistochemical, and molecular study of 19 lesions. Am J Surg Pathol. 2008;32:867–873.
Nishida T, Goto O, Raut CP, et al. Diagnostic and treatment strategy for small gastrointestinal stromal tumors. Cancer. 2016;122:3110–3118.
Agaimy A, Wünsch PH, Hofstaedter F, et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol. 2007;31:113–120.
Lawrence B, Gustafsson BI, Chan A, et al. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Endocrinol Metab Clin North Am. 2011;40:1–18.
Agaimy A, Wünsch PH, Sobin LH, et al. Occurrence of other malignancies in patients with gastrointestinal stromal tumors. Semin Diagn Pathol. 2006;23:120–129.
Ferreira SS, Werutsky G, Toneto MG, et al. Synchronous gastrointestinal stromal tumors (GIST) and other primary cancers: case series of a single institution experience. Int J Surg. 2010;8:314–317.
Vassos N, Agaimy A, Hohenberger W, et al. Coexistence of gastrointestinal stromal tumours (GIST) and malignant neoplasms of different origin: prognostic implications. Int J Surg. 2014;12:371–377.
Hechtman JF, DeMatteo R, Nafa K, et al. Additional primary malignancies in patients with gastrointestinal stromal tumor (GIST): a clinicopathologic study of 260 patients with molecular analysis and review of the literature. Ann Surg Oncol. 2015;22:2633–2639.
Smith MJ, Smith HG, Mahar AL, et al. The impact of additional malignancies in patients diagnosed with gastrointestinal stromal tumors. Int J Cancer. 2016;139:1744–1751.
Murphy JD, Ma GL, Baumgartner JM, et al. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: a population-based study. Cancer. 2015;121:2960–2967.
Valente R, Hayes AJ, Haugvik SP, et al. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms. Endocr Relat Cancer. 2017;24:405–414.
Waidhauser J, Bornemann A, Trepel M, et al. Frequency, localization, and types of gastrointestinal stromal tumor–associated neoplasia. World J Gastroenterol. 2019;25:4261–4277.
Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23:70–83.
Liu Z, Zheng G, Liu J, et al. Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patients. BMC Cancer. 2018;18:563.
Rossi S, Gasparotto D, Toffolatti L, et al. Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size. Am J Surg Pathol. 2010;34:1480–1491.
Mayr P, Märkl B, Agaimy A, et al. Malignancies associated with GIST: a retrospective study with molecular analysis of KIT and PDGFRA. Langenbecks Arch Surg. 2019;404:605–613.